Septerna (SEPN) Change in Receivables (2023 - 2026)
Septerna's quarterly Change in Receivables came in at $486000.0 in Q1 2026, up 515.19% year-on-year from $79000.0 in Q1 2025, and down 71.6% quarter-over-quarter from $1.7 million in Q4 2025.
Septerna has reported Change in Receivables for 4 years, with the latest figure at $486000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 515.19% year-over-year to $486000.0; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (up 7612.06% YoY), and the FY2025 full-year result was $10.2 million, up 50825.0% from the prior year.
- Change in Receivables for Q1 2026 stood at $486000.0, down from $1.7 million in the prior quarter.
- The five-year high for Change in Receivables was $8.5 million in Q3 2025, with the low at -$190000.0 in Q2 2024.
- Average Change in Receivables over 4 years is $1.1 million, with a median of $98500.0 recorded in 2023.
- Year-over-year, Change in Receivables slumped 133.9% in 2024 and jumped 84840.0% in 2025.
- Tracing SEPN's Change in Receivables over 4 years: stood at $118000.0 in 2023, then tumbled by 133.9% to -$40000.0 in 2024, then jumped by 4377.5% to $1.7 million in 2025, then plunged by 71.6% to $486000.0 in 2026.
- The last three Change in Receivables figures came in at $486000.0 (Q1 2026), $1.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 486,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 486,000.00 |
| Mar 31, 2026 | 486,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | -99,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |